Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis. (Q54166672)

25 May 2018

title

Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis. (English)

1 reference

25 May 2018

1 reference

1 reference

Palanivel Chitra

1

1 reference

25 May 2018

Gowrikumar Saiprasad

series ordinal

2

1 reference

25 May 2018

Ramar Manikandan

series ordinal

3

1 reference

25 May 2018

Ganapasam Sudhandiran

series ordinal

4

1 reference

25 May 2018

publication date

17 April 2015

1 reference

25 May 2018

Journal of Molecular Medicine

published in

1 reference

25 May 2018

volume

93

1 reference

25 May 2018

issue

9

1 reference

25 May 2018

page(s)

1015-1031

1 reference

25 May 2018

Determinants of survival in idiopathic pulmonary fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

In vitro anti-fibrotic activities of herbal compounds and herbs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Integrating mechanisms of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Non-Smad transforming growth factor-β signaling regulated by focal adhesion kinase binding the p85 subunit of phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Protein kinase inhibitors in the treatment of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Autophagy: a core cellular process with emerging links to pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

mTOR regulation of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

TGF-beta signaling and the fibrotic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Berberine: a potential phytochemical with multispectrum therapeutic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

FAK integrates growth-factor and integrin signals to promote cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Phosphatidylinositol-3-Kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Epithelial Pten controls acute lung injury and fibrosis by regulating alveolar epithelial cell integrity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Role of caveolin-1 in fibrotic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Insufficient autophagy in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Autophagy in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1283-1

Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase

21 January 2018

1 reference

12 December 2020

Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy.

1 reference

12 December 2020

Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms

1 reference

12 December 2020

Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis

1 reference

12 December 2020

10.1007/S00109-015-1283-1

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018